SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-040363
Filing Date
2019-11-05
Accepted
2019-11-05 16:06:51
Documents
73
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nk-10q_20190930.htm 10-Q 3066035
2 EX-31.1 nk-ex311_8.htm EX-31.1 19714
3 EX-31.2 nk-ex312_9.htm EX-31.2 19699
4 EX-32.1 nk-ex321_10.htm EX-32.1 7351
5 EX-32.2 nk-ex322_7.htm EX-32.2 7285
  Complete submission text file 0001564590-19-040363.txt   10894609

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nk-20190930.xml EX-101.INS 2603140
7 XBRL TAXONOMY EXTENSION SCHEMA nk-20190930.xsd EX-101.SCH 63907
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nk-20190930_cal.xml EX-101.CAL 73818
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nk-20190930_def.xml EX-101.DEF 236184
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nk-20190930_lab.xml EX-101.LAB 531063
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nk-20190930_pre.xml EX-101.PRE 415401
Mailing Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 (858) 633-0300
NantKwest, Inc. (Filer) CIK: 0001326110 (see all company filings)

IRS No.: 431979754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37507 | Film No.: 191193312
SIC: 2836 Biological Products, (No Diagnostic Substances)